Romana R Gerner

Scopus Publications

Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies
Marwa Abdel Hamid, Lorenz M. Pammer, Silvia Oberparleiter, Michael Günther, Arno Amann, et al.
Npj Precision Oncology, 2025
Uniting against enteric invaders: IgA meets its microbial ally
Sophia Adlkirchner, Romana R. Gerner
Cell Host and Microbe, 2025
IL-22-dependent responses and their role during Citrobacter rodentium infection
Karine Melchior, Romana R. Gerner, Suzana Hossain, Sean-Paul Nuccio, Cristiano Gallina Moreira, et al.
Infection and Immunity, 2024
The mouse pathogen Citrobacter rodentium is utilized as a model organism for studying infections caused by the human pathogens enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) and to elucidate mechanisms of mucosal immunity. In response to C. rodentium infection, innate lymphoid cells and T cells secrete interleukin (IL)-22, a cytokine that promotes mucosal barrier function. IL-22 plays a pivotal role in enabling mice to survive and recover from C. rodentium infection, although the exact mechanisms involved remain incompletely understood. Here, we investigated whether particular components of the host response downstream of IL-22 contribute to the cytokine’s protective effects during C. rodentium infection. In line with previous research, mice lacking the IL-22 gene ( Il22 −/− mice) were highly susceptible to C. rodentium infection. To elucidate the role of specific antimicrobial proteins modulated by IL-22, we infected the following knockout mice: S100A9 −/− (calprotectin), Lcn2 −/− (lipocalin-2), Reg3b −/− (Reg3β), Reg3g −/− (Reg3γ), and C3 −/− (C3). All knockout mice tested displayed a considerable level of resistance to C. rodentium infection, and none phenocopied the lethality observed in Il22 −/− mice. By investigating another arm of the IL-22 response, we observed that C. rodentium -infected Il22 −/ − mice exhibited an overall decrease in gene expression related to intestinal barrier integrity as well as significantly elevated colonic inflammation, gut permeability, and pathogen levels in the spleen. Taken together, these results indicate that host resistance to lethal C. rodentium infection may depend on multiple antimicrobial responses acting in concert, or that other IL-22-regulated processes, such as tissue repair and maintenance of epithelial integrity, play crucial roles in host defense to attaching and effacing pathogens.
lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease
Marie Czech, Sophia Schneider, Nina Peltokangas, Nadia El Khawanky, Sakhila Ghimire, et al.
Science Translational Medicine, 2024
Acute graft-versus-host disease (aGVHD) is a life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT), for which therapeutic options are limited. Strategies to promote intestinal tissue tolerance during aGVHD may improve patient outcomes. Using single-cell RNA sequencing, we identified a lipocalin-2 (LCN2)–expressing neutrophil population in mice with intestinal aGVHD. Transfer of LCN2-overexpressing neutrophils or treatment with recombinant LCN2 reduced aGVHD severity, whereas the lack of epithelial or hematopoietic LCN2 enhanced aGVHD severity and caused microbiome alterations. Mechanistically, LCN2 induced insulin-like growth factor 1 receptor (IGF-1R) signaling in macrophages through the LCN2 receptor SLC22A17, which increased interleukin-10 (IL-10) production and reduced major histocompatibility complex class II (MHCII) expression. Transfer of LCN2-pretreated macrophages reduced aGVHD severity but did not reduce graft-versus-leukemia effects. Furthermore, LCN2 expression correlated with IL-10 expression in intestinal biopsies in multiple cohorts of patients with aGVHD, and LCN2 induced IGF-1R signaling in human macrophages. Collectively, we identified a LCN2-expressing intestinal neutrophil population that reduced aGVHD severity by decreasing MHCII expression and increasing IL-10 production in macrophages. This work provides the foundation for administration of LCN2 as a therapeutic approach for aGVHD.
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
Adriana Vasquez Ayala, Chia-Yun Hsu, Renee E. Oles, Kazuhiko Matsuo, Luke R. Loomis, et al.
Journal of Experimental Medicine, 2024
Type I interferons (IFNs) exert a broad range of biological effects important in coordinating immune responses, which have classically been studied in the context of pathogen clearance. Yet, whether immunomodulatory bacteria operate through IFN pathways to support intestinal immune tolerance remains elusive. Here, we reveal that the commensal bacterium, Bacteroides fragilis, utilizes canonical antiviral pathways to modulate intestinal dendritic cells (DCs) and regulatory T cell (Treg) responses. Specifically, IFN signaling is required for commensal-induced tolerance as IFNAR1-deficient DCs display blunted IL-10 and IL-27 production in response to B. fragilis. We further establish that IFN-driven IL-27 in DCs is critical in shaping the ensuing Foxp3+ Treg via IL-27Rα signaling. Consistent with these findings, single-cell RNA sequencing of gut Tregs demonstrated that colonization with B. fragilis promotes a distinct IFN gene signature in Foxp3+ Tregs during intestinal inflammation. Altogether, our findings demonstrate a critical role of commensal-mediated immune tolerance via tonic type I IFN signaling.
Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity
Chia-Hao Lin, Cheng-Jang Wu, Sunglim Cho, Rasika Patkar, William J. Huth, et al.
Nature Immunology, 2023
Murine Models of Salmonella Infection
Gregory T. Walker, Romana R. Gerner, Sean‐Paul Nuccio, Manuela Raffatellu
Current Protocols, 2023
The pathogen Salmonella enterica encompasses a range of bacterial serovars that cause intestinal inflammation and systemic infections in humans. Mice are a widely used infection model due to their relative simplicity and versatility. Here, we provide standardized protocols for culturing the prolific zoonotic pathogen S. enterica serovar Typhimurium for intragastric inoculation of mice to model colitis or systemic dissemination, along with techniques for direct extraintestinal infection. Furthermore, we present procedures for quantifying pathogen burden and for characterizing the immune response by analyzing tissue pathology, inflammatory markers, and immune cells from intestinal tissues. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Murine colitis model utilizing oral streptomycin pretreatment and oral S. Typhimurium administrationBasic Protocol 2: Intraperitoneal injection of S. Typhimurium for modeling extraintestinal infectionSupport Protocol 1: Preparation of S. Typhimurium inoculumSupport Protocol 2: Preparation of mixed S. Typhimurium inoculum for competitive infectionBasic Protocol 3: Assessment of S. Typhimurium burdenSupport Protocol 3: Preservation and pathological assessment of S. Typhimurium–infected tissuesSupport Protocol 4: Measurement of inflammatory marker expression in intestinal tissues by qPCRSupport Protocol 5: Preparation of intestinal content for inflammatory marker quantification by ELISASupport Protocol 6: Immune cell isolation from Salmonella‐infected intestinal tissues
Siderophore Immunization Restricted Colonization of Adherent-Invasive Escherichia coli and Ameliorated Experimental Colitis
Romana R. Gerner, Suzana Hossain, Artur Sargun, Kareem Siada, Grant J. Norton, et al.
Mbio, 2022
Adherent-invasive Escherichia coli (AIEC) is abnormally prevalent in patients with ileal Crohn’s disease and exacerbates intestinal inflammation, but treatment strategies that selectively target AIEC are unavailable. Iron is an essential micronutrient for most living organisms, and bacterial pathogens have evolved sophisticated strategies to capture iron from the host environment.
Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity
Robert H. Mills, Parambir S. Dulai, Yoshiki Vázquez-Baeza, Consuelo Sauceda, Noëmie Daniel, et al.
Nature Microbiology, 2022
Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut
Judith Behnsen, Hui Zhi, Allegra T. Aron, Vivekanandan Subramanian, William Santus, et al.
Nature Communications, 2021
Zinc is an essential cofactor for bacterial metabolism, and many Enterobacteriaceae express the zinc transporters ZnuABC and ZupT to acquire this metal in the host. However, the probiotic bacterium Escherichia coli Nissle 1917 (or “Nissle”) exhibits appreciable growth in zinc-limited media even when these transporters are deleted. Here, we show that Nissle utilizes the siderophore yersiniabactin as a zincophore, enabling Nissle to grow in zinc-limited media, to tolerate calprotectin-mediated zinc sequestration, and to thrive in the inflamed gut. We also show that yersiniabactin’s affinity for iron or zinc changes in a pH-dependent manner, with increased relative zinc binding as the pH increases. Thus, our results indicate that siderophore metal affinity can be influenced by the local environment and reveal a mechanism of zinc acquisition available to commensal and pathogenic Enterobacteriaceae.
Harnessing iron acquisition machinery to target enterobacteriaceae
Artur Sargun, Romana R Gerner, Manuela Raffatellu, Elizabeth M Nolan
Journal of Infectious Diseases, 2021
Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease
Lisa Mayr, Felix Grabherr, Julian Schwärzler, Isabelle Reitmeier, Felix Sommer, et al.
Nature Communications, 2020
CD8 T cells drive anorexia, dysbiosis, and blooms of a commensal with immunosuppressive potential after viral infection
Lara Labarta-Bajo, Anna Gramalla-Schmitz, Romana R. Gerner, Katelynn R. Kazane, Gregory Humphrey, et al.
Proceedings of the National Academy of Sciences of the United States of America, 2020
Iron at the host-microbe interface
Romana R. Gerner, Sean-Paul Nuccio, Manuela Raffatellu
Molecular Aspects of Medicine, 2020
Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity
Romana R. Gerner, Sophie Macheiner, Simon Reider, Kerstin Siegmund, Felix Grabherr, et al.
Leukemia, 2020
Gut pain sensors help to combat infection
Romana R. Gerner, Manuela Raffatellu
Nature, 2020
Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis
Victoria Klepsch, Romana R Gerner, Sebastian Klepsch, William J Olson, Herbert Tilg, et al.
Gut, 2018
The Intestinal Microbiota in Colorectal Cancer
Herbert Tilg, Timon E. Adolph, Romana R. Gerner, Alexander R. Moschen
Cancer Cell, 2018
A Worm's Gut Feelings: Neuronal Muscarinic and Epithelial Canonical Wnt Pathways Promote Antimicrobial Defense
Romana R. Gerner, Manuela Raffatellu
Immunity, 2018
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
Christoph Grander, Timon E Adolph, Verena Wieser, Patrick Lowe, Laura Wrzosek, et al.
Gut, 2018
NAD metabolism fuels human and mouse intestinal inflammation
Romana R Gerner, Victoria Klepsch, Sophie Macheiner, Kathrin Arnhard, Timon E Adolph, et al.
Gut, 2018
Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation
Alexander R. Moschen, Timon E. Adolph, Romana R. Gerner, Verena Wieser, Herbert Tilg
Trends in Endocrinology and Metabolism, 2017
Treatment with α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease: A Report of 2 Cases
Romana Raphaela Gerner, Clemens Feistritzer, Alexander Rupert Moschen, Brigitte Kircher, Patrizia Moser, et al.
Transplantation, 2016
Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations
Alexander R. Moschen, Romana R. Gerner, Jun Wang, Victoria Klepsch, Timon E. Adolph, et al.
Cell Host and Microbe, 2016
Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease
Verena Wieser, Piotr Tymoszuk, Timon Erik Adolph, Christoph Grander, Felix Grabherr, et al.
Journal of Hepatology, 2016
Adult Human and Mouse Ovaries Lack DDX4-Expressing Functional Oogonial Stem Cells
Hua Zhang, Sarita Panula, Sophie Petropoulos, Daniel Edsgärd, Kiran Busayavalasa, et al.
Obstetrical and Gynecological Survey, 2016
Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response
Manfred Nairz, Andrea Schroll, David Haschka, Stefanie Dichtl, Thomas Sonnweber, et al.
European Journal of Immunology, 2015
Adult human and mouse ovaries lack DDX4-expressing functional oogonial stem cells
Hua Zhang, Sarita Panula, Sophie Petropoulos, Daniel Edsgärd, Kiran Busayavalasa, et al.
Nature Medicine, 2015
Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2
Ivan Tancevski, Manfred Nairz, Kristina Duwensee, Kristina Auer, Andrea Schroll, et al.
EMBO Molecular Medicine, 2014
Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity
Alexander R. Moschen, Verena Wieser, Romana R. Gerner, Alexandra Bichler, Barbara Enrich, et al.
Journal of Hepatology, 2013
Liver complications in inflammatory bowel diseases
V. Wieser, R. Gerner, A.R. Moschen, H. Tilg
Digestive Diseases, 2013
Metabolic inflammation: Role of cytokines in the crosstalk between adipose tissue and liver1
Romana R. Gerner, Verena Wieser, Alexander R. Moschen, Herbert Tilg
Canadian Journal of Physiology and Pharmacology, 2013
Targeting T and B lymphocytes in inflammatory bowel diseases: Lessons from clinical trials
R.R. Gerner, A.R. Moschen, H. Tilg
Digestive Diseases, 2013
A key role for Pre-B cell colony-enhancing factor in experimental hepatitis
Alexander R. Moschen, Romana Gerner, Andrea Schroll, Teresa Fritz, Arthur Kaser, et al.
Hepatology, 2011
Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
Alexander R. Moschen, Sabine Geiger, Romana Gerner, Herbert Tilg
Mutation Research Fundamental and Molecular Mechanisms of Mutagenesis, 2010
Pre-b cell colony enhancing factor/nampt/visfatin in inflammation and obesityrelated disorders
Alexander R. Moschen, Romana R. Gerner, Herbert Tilg
Current Pharmaceutical Design, 2010

RECENT SCHOLAR PUBLICATIONS

Immunomodulatory metabolites define long-term gut microbiome recovery after allogeneic HCT and associate with improved survival and reduced relapse related mortality
A Schwarz, T Eismann, T Zheng, S Holzinger, A Denk, S Goeldel, ...
medRxiv, 2026.03. 26.26349381 , 2026
2026
Escherichia coli shapes intestinal B-cell responses and influences susceptibility to Inflammatory Bowel Disease
S Adlkirchner, V Becker, V Betz, K Muhlschlegel, M Hubersberger, ...
JOURNAL OF CROHNS & COLITIS 20 , 2026
2026
DOP144 Escherichia coli shapes intestinal B-cell responses and influences susceptibility to Inflammatory Bowel Disease
S Adlkirchner, V Becker, V Betz, K Mühlschlegel, M Hubersberger, ...
Journal of Crohn’s and Colitis 20 (Supplement_1), jjaf231. 181 , 2026
2026
The role of microbial metabolites in fecal microbiota transplantation in patients with acute gvhd of the gut
A Schwarz, S Holzinger, P Herhaus, M Verbeek, K Neuhaus, K Kleigrewe, ...
Blood 146 (Supplement 1), 4236-4236 , 2025
2025
Commensal Escherichia coli colonization triggers Peyer’s patch development
RR Gerner, GT Walker, SM Klaus, K Melchior, S Hossain, K Siada, ...
bioRxiv, 2025.10. 06.680803 , 2025
2025
Uniting against enteric invaders: IgA meets its microbial ally
S Adlkirchner, RR Gerner
Cell Host & Microbe 33 (6), 932-934 , 2025
2025
Multidimensional differences of right-and left-sided colorectal cancer and their impact on targeted therapies
MA Hamid, LM Pammer, S Oberparleiter, M Günther, A Amann, ...
NPJ precision oncology 9, 116 , 2025
2025
Citations: 17
Multidimensional differences of right-and left-sided colorectal cancer and their impact on targeted therapies
M Abdel Hamid, LM Pammer, S Oberparleiter, M Günther, A Amann, ...
npj Precision Oncology 9 (1), 116 , 2025
2025
Citations: 20
Clonal Hematopoiesis and Immune Cell Phenotypes as Predictive Biomarkers of CAR-T Therapy Outcomes in Multiple Myeloma
A Purcarea, S Baumann, S Stein, J Ferstl, F Bassermann, RR Gerner, ...
2025
Loss of Microbiota-Derived Metabolites Is Associated with Mucosal-Barrier-Injury Bloodstream Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
S Göldel, T Zheng, T Eismann, M Tiefgraber, M Urban, A Schwarz, ...
Blood 144 (Supplement 1), 4904-4904 , 2024
2024
CCL28 modulates neutrophil responses during infection with mucosal pathogens
GT Walker, A Perez-Lopez, S Silva, MH Lee, E Bjånes, N Dillon, ...
Elife 13, e78206 , 2024
2024
Citations: 7
IL-22-dependent responses and their role during Citrobacter rodentium infection
K Melchior, RR Gerner, S Hossain, SP Nuccio, CG Moreira, M Raffatellu
Infection and immunity 92 (5), e00099-24 , 2024
2024
Citations: 19
Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease
M Czech, S Schneider, N Peltokangas, N El Khawanky, S Ghimire, ...
Science translational medicine 16 (735), eadi1501 , 2024
2024
Citations: 31
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
A Vasquez Ayala, CY Hsu, RE Oles, K Matsuo, LR Loomis, E Buzun, ...
Journal of Experimental Medicine 221 (1), e20230063 , 2023
2023
Citations: 52
Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of T H 17 cell immunity
CH Lin, CJ Wu, S Cho, R Patkar, WJ Huth, LL Lin, MC Chen, E Israelsson, ...
Nature immunology 24 (12), 2108-2120 , 2023
2023
Citations: 44
Murine Models of Salmonella Infection
GT Walker, RR Gerner, SP Nuccio, M Raffatellu
Current protocols 3 (7), e824 , 2023
2023
Citations: 40
Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of Th17 immunity
CH Lin, CJ Wu, S Cho, R Patkar, LL Lin, MC Chen, E Israelsson, J Betts, ...
bioRxiv , 2023
2023
Citations: 3
Siderophore Immunization Restricted Colonization of Adherent-Invasive Escherichia
RR Gerner, S Hossain, A Sargun
mBio, 13 (5) , 2022
2022
Siderophore immunization restricted colonization of adherent-invasive Escherichia coli and ameliorated experimental colitis
RR Gerner, S Hossain, A Sargun, K Siada, GJ Norton, T Zheng, ...
MBio 13 (5), e02184-22 , 2022
2022
Citations: 27
Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity
RH Mills, PS Dulai, Y Vázquez-Baeza, C Sauceda, N Daniel, RR Gerner, ...
Nature microbiology 7 (2), 262-276 , 2022
2022
Citations: 389

MOST CITED SCHOLAR PUBLICATIONS

The intestinal microbiota in colorectal cancer
H Tilg, TE Adolph, RR Gerner, AR Moschen
Cancer cell 33 (6), 954-964 , 2018
2018
Citations: 910
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
C Grander, TE Adolph, V Wieser, P Lowe, L Wrzosek, B Gyongyosi, ...
Gut 67 (5), 891-901 , 2018
2018
Citations: 702
Lipocalin-2: a master mediator of intestinal and metabolic inflammation
AR Moschen, TE Adolph, RR Gerner, V Wieser, H Tilg
Trends in Endocrinology & Metabolism 28 (5), 388-397 , 2017
2017
Citations: 418
Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations
AR Moschen, RR Gerner, J Wang, V Klepsch, TE Adolph, SJ Reider, ...
Cell host & microbe 19 (4), 455-469 , 2016
2016
Citations: 391
Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity
RH Mills, PS Dulai, Y Vázquez-Baeza, C Sauceda, N Daniel, RR Gerner, ...
Nature microbiology 7 (2), 262-276 , 2022
2022
Citations: 389
Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease
L Mayr, F Grabherr, J Schwärzler, I Reitmeier, F Sommer, T Gehmacher, ...
Nature communications 11 (1), 1775 , 2020
2020
Citations: 306
NAD metabolism fuels human and mouse intestinal inflammation
RR Gerner, V Klepsch, S Macheiner, K Arnhard, TE Adolph, C Grander, ...
Gut 67 (10), 1813-1823 , 2018
2018
Citations: 212
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders
A R Moschen, R R Gerner, H Tilg
Current pharmaceutical design 16 (17), 1913-1920 , 2010
2010
Citations: 165
Adult human and mouse ovaries lack DDX4-expressing functional oogonial stem cells
H Zhang, S Panula, S Petropoulos, D Edsgärd, K Busayavalasa, L Liu, ...
Nature medicine 21 (10), 1116-1118 , 2015
2015
Citations: 154
Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity
AR Moschen, V Wieser, RR Gerner, A Bichler, B Enrich, P Moser, ...
Journal of hepatology 59 (6), 1315-1322 , 2013
2013
Citations: 118
Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease
V Wieser, P Tymoszuk, TE Adolph, C Grander, F Grabherr, B Enrich, ...
Journal of Hepatology 64 (4), 872-880 , 2016
2016
Citations: 111
Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver
RR Gerner, V Wieser, AR Moschen, H Tilg
Canadian journal of physiology and pharmacology 91 (11), 867-872 , 2013
2013
Citations: 102
Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
AR Moschen, S Geiger, R Gerner, H Tilg
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 690 (1 … , 2010
2010
Citations: 101
Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut
J Behnsen, H Zhi, AT Aron, V Subramanian, W Santus, MH Lee, ...
Nature Communications 12 (1), 7016 , 2021
2021
Citations: 92
Lipocalin‐2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response
M Nairz, A Schroll, D Haschka, S Dichtl, T Sonnweber, I Theurl, M Theurl, ...
European journal of immunology 45 (11), 3073-3086 , 2015
2015
Citations: 77
Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat Microbiol 7: 262–276
RH Mills, PS Dulai, Y Vázquez-Baeza, C Sauceda, N Daniel, RR Gerner, ...
2022
Citations: 55
Liver complications in inflammatory bowel diseases
V Wieser, R Gerner, AR Moschen, H Tilg
Digestive diseases 31 (2), 233-238 , 2013
2013
Citations: 54
Iron at the host-microbe interface
RR Gerner, SP Nuccio, M Raffatellu
Molecular Aspects of Medicine 75, 100895 , 2020
2020
Citations: 53
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
A Vasquez Ayala, CY Hsu, RE Oles, K Matsuo, LR Loomis, E Buzun, ...
Journal of Experimental Medicine 221 (1), e20230063 , 2023
2023
Citations: 52
Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis
V Klepsch, RR Gerner, S Klepsch, WJ Olson, H Tilg, AR Moschen, G Baier, ...
Gut 67 (8), 1434-1444 , 2018
2018
Citations: 48

Romana R Gerner

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS